These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32164395)

  • 1. Quantitative Assessment of Gait Characteristics in Degenerative Cervical Myelopathy: A Prospective Clinical Study.
    Kalsi-Ryan S; Rienmueller AC; Riehm L; Chan C; Jin D; Martin AR; Badhiwala JH; Akbar MA; Massicotte EM; Fehlings MG
    J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32164395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degenerative cervical myelopathy: establishing severity thresholds for neuromotor dysfunction in the aging spine using the NIH Toolbox Assessment Scale.
    Muhammad F; Hameed S; Haynes G; Mohammadi E; Khan AF; Shakir H; Smith ZA
    Geroscience; 2024 Apr; 46(2):2197-2206. PubMed ID: 37880488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the minimum clinically important difference in patients undergoing surgery for the treatment of degenerative cervical myelopathy.
    Tetreault L; Wilson JR; Kotter MR; Nouri A; Côté P; Kopjar B; Arnold PM; Fehlings MG
    Neurosurg Focus; 2016 Jun; 40(6):E14. PubMed ID: 27246484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter-rater Reliability of the Modified Japanese Orthopedic Association Score in Degenerative Cervical Myelopathy: A Cross-sectional Study.
    Martin AR; Jentzsch T; Wilson JRF; Moghaddamjou A; Jiang F; Rienmueller A; Badhiwala JH; Akbar MA; Nater A; Oitment C; Ganau M; Massicotte EM; Fehlings MG
    Spine (Phila Pa 1976); 2021 Aug; 46(16):1063-1069. PubMed ID: 33492085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Upper Limb Impairment Related to Degenerative Cervical Myelopathy: Development of a Sensitive Hand Assessment (Graded Redefined Assessment of Strength, Sensibility, and Prehension Version Myelopathy).
    Kalsi-Ryan S; Riehm LE; Tetreault L; Martin AR; Teoderascu F; Massicotte E; Curt A; Verrier MC; Velstra IM; Fehlings MG
    Neurosurgery; 2020 Mar; 86(3):E292-E299. PubMed ID: 31792501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of nonoperatively managed degenerative cervical myelopathy: an ambispective longitudinal cohort study in 117 patients.
    Martin AR; Kalsi-Ryan S; Akbar MA; Rienmueller AC; Badhiwala JH; Wilson JR; Tetreault LA; Nouri A; Massicotte EM; Fehlings MG
    J Neurosurg Spine; 2021 Apr; 34(6):821-829. PubMed ID: 33836502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The modified Japanese Orthopaedic Association scale: establishing criteria for mild, moderate and severe impairment in patients with degenerative cervical myelopathy.
    Tetreault L; Kopjar B; Nouri A; Arnold P; Barbagallo G; Bartels R; Qiang Z; Singh A; Zileli M; Vaccaro A; Fehlings MG
    Eur Spine J; 2017 Jan; 26(1):78-84. PubMed ID: 27342612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Is Spinal Cord Function Measured in Degenerative Cervical Myelopathy? A Systematic Review.
    Soufi KH; Perez TM; Umoye AO; Yang J; Burgos M; Martin AR
    J Clin Med; 2022 Mar; 11(5):. PubMed ID: 35268533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gait assessment tools for degenerative cervical myelopathy: a systematic review.
    Choy WJ; Chen L; Quel De Oliveira C; Verhagen AP; Damodaran O; Anderson DB
    J Spine Surg; 2022 Mar; 8(1):149-162. PubMed ID: 35441108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of symptoms in the quantification of upper limb disability and impairment for individuals with mild degenerative cervical myelopathy (DCM).
    Kalsi-Ryan S; Clout J; Rostami P; Massicotte EM; Fehlings MG
    PLoS One; 2019; 14(9):e0222134. PubMed ID: 31498813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelopathy disability index: establishing criteria for mild, moderate and severe impairment in patients with degenerative cervical myelopathy.
    Pons Carreto A; Ramírez Valencia M; de García Frutos A; Khoudeir Avila A; Montesinos Magraner L; Nuñez-Pereira S; Haddad S; Pellisé Urquiza F
    Eur Spine J; 2023 Feb; 32(2):584-589. PubMed ID: 36596911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Clinical Practice Guideline for the Management of Degenerative Cervical Myelopathy: Introduction, Rationale, and Scope.
    Fehlings MG; Tetreault LA; Riew KD; Middleton JW; Wang JC
    Global Spine J; 2017 Sep; 7(3 Suppl):21S-27S. PubMed ID: 29164027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Minimum Clinically Important Difference of the Modified Japanese Orthopaedic Association Scale in Patients with Degenerative Cervical Myelopathy.
    Tetreault L; Nouri A; Kopjar B; Côté P; Fehlings MG
    Spine (Phila Pa 1976); 2015 Nov; 40(21):1653-9. PubMed ID: 26502097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Preoperative Duration of Symptoms a Significant Predictor of Functional Outcomes in Patients Undergoing Surgery for the Treatment of Degenerative Cervical Myelopathy?
    Tetreault L; Wilson JR; Kotter MRN; Côté P; Nouri A; Kopjar B; Arnold PM; Fehlings MG
    Neurosurgery; 2019 Nov; 85(5):642-647. PubMed ID: 30445506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric properties of the 30-m walking test in patients with degenerative cervical myelopathy: results from two prospective multicenter cohort studies.
    Bohm PE; Fehlings MG; Kopjar B; Tetreault LA; Vaccaro AR; Anderson KK; Arnold PM
    Spine J; 2017 Feb; 17(2):211-217. PubMed ID: 27592193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the patient-derived modified Japanese Orthopaedic Association scale and the European myelopathy score.
    de Dios E; Löfgren H; Laesser M; Lindhagen L; Björkman-Burtscher IM; MacDowall A
    Eur Spine J; 2024 Mar; 33(3):1205-1212. PubMed ID: 38112768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of post-operative recall by degenerative cervical myelopathy patients using the modified Japanese Orthopaedic Association scale.
    Chang S; Xu N; Luo Y; Wang S; Liu Z
    J Clin Transl Res; 2022 Dec; 8(6):594-601. PubMed ID: 36683652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degenerative Cervical Myelopathy in Higher-Aged Patients: How Do They Benefit from Surgery?
    Gembruch O; Jabbarli R; Rashidi A; Chihi M; El Hindy N; Wetter A; Hütter BO; Sure U; Dammann P; Özkan N
    J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31888031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First neurological symptoms in degenerative cervical myelopathy: does it predict the outcome?
    Özkan N; Chihi M; Schoemberg T; Dinger TF; Helsper M; Parlak A; Jabbarli R; Ahmadipour Y; Sure U; El Hindy N; Gembruch O
    Eur Spine J; 2022 Feb; 31(2):327-333. PubMed ID: 34822020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laminectomy and fusion versus laminoplasty for the treatment of degenerative cervical myelopathy: results from the AOSpine North America and International prospective multicenter studies.
    Fehlings MG; Santaguida C; Tetreault L; Arnold P; Barbagallo G; Defino H; Kale S; Zhou Q; Yoon TS; Kopjar B
    Spine J; 2017 Jan; 17(1):102-108. PubMed ID: 27597512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.